Discover
VRNA
Verona Pharma plc
106.91
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 130.21% | |
| 1y | 233.99% |
106.91
day range
106.91
31.60
52 week range
106.93
| Open | 106.85 | Prev Close | 106.91 | Low | 106.91 | High | 106.91 | Mkt Cap | 9.09B |
| Vol | 1.87M | Avg Vol | 1.69M | EPS | -1.04 | P/E | N/A | Forward P/E | -381.82 |
| Beta | 0.05 | Short Ratio | 1.56 | Inst. Own | 92.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 105.95 | 200-d Avg | 79.84 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 103.14M | ||
| Revenues (USD) | 103.14M | ||
| Cost of Revenue | 4.76M | ||
| Gross Profit | 98.38M | ||
| Operating Expenses | 85.08M | ||
| Research and Development Expense | 12.95M | ||
| Selling, General and Administrative Expense | 72.13M | ||
| Operating Income | 13.31M | ||
| Interest Expense | 6.82M | ||
| Income Tax Expense | -39.00K | ||
| Net Income | 11.92M | ||
| Net Income Common Stock | 11.92M | ||
| Net Income Common Stock (USD) | 11.92M | ||
| Consolidated Income | 11.92M | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 18.70M | ||
| Earning Before Interest & Taxes (USD) | 18.70M | ||
| Weighted Average Shares | 685.16M | ||
| Weighted Average Shares Diluted | 727.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 438.02M | ||
| Cash and Equivalents (USD) | 438.02M | ||
| Investments | 15.00M | ||
| Investments Non-Current | 15.00M | ||
| Trade and Non-Trade Receivables | 82.86M | ||
| Current Assets | 548.85M | ||
| Property, Plant & Equipment Net | 2.57M | ||
| Total Assets | 572.87M | ||
| Debt Current | 1.01M | ||
| Total Debt | 244.37M | ||
| Current Liabilities | 51.24M | ||
| Debt Non-Current | 243.36M | ||
| Total Liabilities | 294.60M | ||
| Accumulated Retained Earnings (Deficit) | -567.10M | ||
| Accumulated Other Comprehensive Income | -4.60M | ||
| Shareholders Equity | 278.27M | ||
| Shareholders Equity (USD) | 278.27M | ||
| Assets Non-Current | 24.02M | ||
| Total Debt (USD) | 244.37M | ||
| Goodwill and Intangible Assets | 545.00K | ||
| Inventory | 14.52M | ||
| Liabilities Non-Current | 243.36M | ||
| Trade and Non-Trade Payables | 6.52M | ||
| Tax Assets | 4.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 293.00K | ||
| Net Cash Flow from Financing | 4.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 36.60M | ||
| Issuance (Purchase) of Equity Shares | 4.94M | ||
| Net Cash Flow from Operations | 30.56M | ||
| Effect of Exchange Rate Changes on Cash | 1.10M | ||
| Share Based Compensation | 34.81M | ||